Production of chiral 1,2-amino alcohols and alpha-amino acids from alkenes by cascade biocatalysis
US-2017067084-A1 · Mar 9, 2017 · US
US11060076B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11060076-B2 |
| Application number | US-201916682486-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 13, 2019 |
| Priority date | Nov 13, 2018 |
| Publication date | Jul 13, 2021 |
| Grant date | Jul 13, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a method for producing a 1,2-amino alcohol compound by utilizing whole-cell transformation, and belongs to the technical field of gene engineering and microorganism engineering. According to the present invention, engineered Escherichia coli co-expresses epoxide hydrolase, alcohol dehydrogenase, ω-transaminase and glutamate dehydrogenase, is capable of realizing whole-cell catalysis of an epoxide in one step to synthesize a 1,2-amino alcohol compound, and meanwhile, can realize regeneration of coenzyme NADP + and an amino doner L-Glu; alcohol dehydrogenase expressed by the engineered Escherichia coli is RBS optimized alcohol dehydrogenase, and such RBS optimization can control the expression quantity of alcohol dehydrogenase, so that the catalysis rate of alcohol dehydrogenase and transaminase can achieve an optimum ratio, to eliminate influence caused by a rate-limiting step in a catalyzing course.
Opening claim text (preview).
What is claimed is: 1. An engineered Escherichia coli , wherein the engineered Escherichia coli comprises recombinant plasmid A and recombinant plasmid B; the recombinant plasmid A comprising a target gene A and an expression vector; the recombinant plasmid B comprising a target gene B, a target gene C, and an expression vector; the target gene A being a gene encoding epoxide hydrolase (SpEH) comprising SEQ ID NO: 1; the target gene B being a gene encoding alcohol dehydrogenase (MnADH) comprising SEQ ID NO: 2; the target gene C being a gene encoding w-transaminase (PAKω-TA), wherein the amino acid sequence expressed by target gene C comprises SEQ ID NO: 3; and wherein the recombinant plasmid A also comprises a target gene D; the target gene D being a gene encoding glutamate dehydrogenase (GluDH) comprising SEQ ID NO: 5. 2. The engineered Escherichia coli according to claim 1 , wherein the alcohol dehydrogenase (MnADH) is optimized by RBS; RBS optimization of alcohol dehydrogenase (MnADH) meaning that an RBS sequence used for regulating alcohol dehydrogenase (MnADH) and located at the upstream of alcohol dehydrogenase (MnADH) on recombinant plasmid B is substituted; the substituted RBS sequence comprising SEQ ID NO: 4. 3. A method for producing a 1,2-amino alcohol compound, wherein the method uses the engineered Escherichia coli described in claim 1 . 4. A method for producing a 1,2-amino alcohol compound, the method comprising: providing a catalysis system comprising a substrate selected from epoxyethylbenzene, epoxypropane, epoxybutane, epichlorohydrin or epoxypentane and the engineered Escherichia coli according to claim 1 , adding coenzyme NADP+, amino donor L-Glu, and ammonium chloride, and reacting for 10-15 hours.
Amines; Imines · CPC title
transferring nitrogenous groups (2.6) · CPC title
Hydrolases (3) · CPC title
Beta-alanine-pyruvate transaminase (2.6.1.18) · CPC title
Glutamate dehydrogenase (1.4.1.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.